Verition Fund Management’s CARGO Therapeutics CRGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-91,405
Closed -$372K 3668
2025
Q1
$372K Buy
91,405
+52,165
+133% +$349K ﹤0.01% 2757
2024
Q4
$566K Buy
+39,240
New +$712K ﹤0.01% 2408
2024
Q3
Sell
-21,536
Closed -$354K 3243
2024
Q2
$354K Buy
+21,536
New +$409K ﹤0.01% 2250

Other funds holding CRGX

Verition Fund Management's CRGX Position: Q2 2025 in Review

Verition Fund Management sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 91,405 shares — an estimated $372K sold.

Verition Fund Management first reported a position in CRGX in Q2 2024 and held it in 3 quarters. The position peaked at $566K in Q4 2024. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

  • Verition Fund Management reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 91,405 CARGO Therapeutics shares in Q2 2025, an estimated $372K.
  • Verition Fund Management first reported a position in CARGO Therapeutics in Q2 2024 and held it in 3 quarters.
  • Verition Fund Management's CARGO Therapeutics position peaked at $566K in Q4 2024.
  • 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.